These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16165244)

  • 41. Quantification of sodium lauryl sulfate penetration into the skin and underlying tissue after topical application--pharmacological and toxicological implications.
    Patil S; Singh P; Sarasour K; Maibach H
    J Pharm Sci; 1995 Oct; 84(10):1240-4. PubMed ID: 8801341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flux enhancement effects of ionic surfactants upon passive and electroosmotic transdermal transport.
    Peck KD; Hsu J; Li SK; Ghanem AH; Higuchi WI
    J Pharm Sci; 1998 Sep; 87(9):1161-9. PubMed ID: 9724571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of topical laurocapram (Azone) on the in vitro percutaneous permeation of sodium lauryl sulfate using human skin.
    Szolar-Platzer C; Patil S; Maibach HI
    Acta Derm Venereol; 1996 May; 76(3):182-5. PubMed ID: 8800295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.
    Crison JR; Weiner ND; Amidon GL
    J Pharm Sci; 1997 Mar; 86(3):384-8. PubMed ID: 9050810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual effects of sodium lauryl sulphate on human oral epithelial structure.
    Neppelberg E; Costea DE; Vintermyr OK; Johannessen AC
    Exp Dermatol; 2007 Jul; 16(7):574-9. PubMed ID: 17576237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol.
    Hamed R; Alnadi SH; Awadallah A
    AAPS PharmSciTech; 2020 May; 21(5):146. PubMed ID: 32435989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Why is sodium cocoyl isethionate (SCI) mild to the skin barrier? - An in vitro investigation based on the relative sizes of the SCI micelles and the skin aqueous pores.
    Ghosh S; Blankschtein D
    J Cosmet Sci; 2007; 58(3):229-44. PubMed ID: 17598025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic effect of low-frequency ultrasound and surfactants on skin permeability.
    Tezel A; Sens A; Tuchscherer J; Mitragotri S
    J Pharm Sci; 2002 Jan; 91(1):91-100. PubMed ID: 11782900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol.
    Kim YC; Park JH; Ludovice PJ; Prausnitz MR
    Int J Pharm; 2008 Mar; 352(1-2):129-38. PubMed ID: 18079075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe.
    Aburub A; Risley DS; Mishra D
    Int J Pharm; 2008 Jan; 347(1-2):16-22. PubMed ID: 17656053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal drug delivery with a pressure wave.
    Doukas AG; Kollias N
    Adv Drug Deliv Rev; 2004 Mar; 56(5):559-79. PubMed ID: 15019746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhodamine-123: a p-glycoprotein marker complex with sodium lauryl sulfate.
    Al-Mohizea AM; Al-Jenoobi FI; Alam MA
    Pak J Pharm Sci; 2015 Mar; 28(2):617-22. PubMed ID: 25730814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of surfactants on the skin penetration of diazepam.
    Shokri J; Nokhodchi A; Dashbolaghi A; Hassan-Zadeh D; Ghafourian T; Barzegar Jalali M
    Int J Pharm; 2001 Oct; 228(1-2):99-107. PubMed ID: 11576772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel characteristics of sophorolipids, yeast glycolipid biosurfactants, as biodegradable low-foaming surfactants.
    Hirata Y; Ryu M; Oda Y; Igarashi K; Nagatsuka A; Furuta T; Sugiura M
    J Biosci Bioeng; 2009 Aug; 108(2):142-6. PubMed ID: 19619862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate.
    Guo Y; Wang C; Dun J; Du L; Hawley M; Sun CC
    J Pharm Sci; 2019 Jan; 108(1):516-524. PubMed ID: 30389564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Permeability of human skin to selected anions and cations--in vitro studies.
    Laudańska H; Lemancewicz A; Kretowska M; Reduta T; Laudański T
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):16-26. PubMed ID: 15080493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined effects of NaF and SLS on acid- and polysaccharide-formation of biofilm and planktonic cells.
    Petersen FC; Assev S; Scheie AA
    Arch Oral Biol; 2006 Aug; 51(8):665-71. PubMed ID: 16540078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Oleyl pyroglutamate for use as transdermal enhancer and its enhancing mechanism].
    Cheng ZY; Chen HF
    Yao Xue Xue Bao; 2003 May; 38(5):384-7. PubMed ID: 12958846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.